Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Global Anaesthesia Drugs Market Set To Grow To $10.5bn By 2022By: Visiongain This anaesthesia drugs market can be broadly segmented into type and routes of administration. The market is segregated further by type as local anaesthesia and general anaesthesia. Inhalation intravenous and topical are the main forms of routes of administration. The market has also been geographically segmented into North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Asia-Pacific (India, China, Japan, Rest of Asia-Pacific) The lead analyst of the report commented "The global anaesthesia drugs market is projected to grow at lucrative rate during the forecast period owing to a rising number of surgical procedures globally, developing healthcare infrastructure in emerging economies, and growing number of geriatric population. The escalating prevalence of cancer, stroke, arthritis, and neurological diseases leads to a rising number of surgical procedures. In addition, rising number of road accidents and trauma cases will further drive the growth of the market." Leading companies featured in the report include Baxter International, Inc., AbbVie, PAION AG, Pfizer, Hameln Pharmaceuticals, AstraZeneca, Fresenius Kabi, Maruishi Pharmaceuticals, Pacira Pharmaceuticals, Inc Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@ About visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to- Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on. End
Account Phone Number Disclaimer Report Abuse
|
|